FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage
- Authors: Lombardi, Rosa; Petta, Salvatore; Pisano, Giuseppina; Dongiovanni, Paola; Rinaldi, Luca; Adinolfi, Luigi Elio; Acierno, Carlo; Valenti, Luca; Boemi, Roberta; Spatola, Federica; Craxì, Antonio; Fargion, Silvia; Fracanzani, Anna Ludovica
- Publication year: 2020
- Type: Articolo in rivista (Abstract in rivista)
- OA Link: http://hdl.handle.net/10447/344490
Abstract
Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.1.